Chronic Kidney Disease stage3
Nephrology·MeSH: Hyperparathyroidism, Secondary
Prevalence
15000.0 / 100K
Incidence
500.0 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ctap101 | OPKO HEALTH, INC. (OPK) |
Frequently asked questions
How many drugs are in development for Chronic Kidney Disease stage3?
BioSniper tracks 1 drug in development for Chronic Kidney Disease stage3 across 1 company.
How many clinical trials target Chronic Kidney Disease stage3?
There are 3 clinical trials targeting Chronic Kidney Disease stage3 tracked by BioSniper.
What is the prevalence of Chronic Kidney Disease stage3?
The estimated prevalence of Chronic Kidney Disease stage3 is approximately 15000.0 per 100,000 population.
Deep-dive into Chronic Kidney Disease stage3
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis